There's no rule that says a leading pharma stock can't go down. On that note, shares of Eli Lilly (NYSE: LLY) are still down by 7% from their recent high set in mid-August, even though its moneymaker metabolic medicines…
(RTTNews) - After seeing considerable volatility early in the session, Canadian stocks spent much of Tuesday's trading in the red but regained ground going into the end of the day.
The S&P 500 Index ($SPX) (SPY) closed down by -0.77% on Monday, the Dow Jones Industrial Average ($DOWI) (DIA) closed down by -0.67%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -1.08%. December E-mini S&P future…
(RTTNews) - While reporting financial results for the third quarter on Tuesday, leisure travel company Carnival Corp. & plc (CCL, CUK) provided adjusted earnings guidance for the fourth quarter, and raised adjusted earn…
(RTTNews) - American Express Canada (AXP) on Tuesday unveiled its enhanced Aeroplan co-brand Card portfolio, with new travel, lounge, dining and rewards benefits taking effect January 12, 2027.
Cathie Wood, CEO of Ark Invest, believes robotaxis will one day be a $10 trillion global industry. A survey of experts by McKinsey & Co., meanwhile, estimates that "the global rollout of robotaxis is now expected to bec…
(RTTNews) - Tuesday, CDT Equity (CDT) said Sarborg Limited has filed new intellectual property applying quantum sampling to disease biology and drug discovery.
(RTTNews) - Innovent Biologics, Inc. (1801.HK), a biopharmaceutical company, announced updated Phase 1 clinical data for IBI3003 in patients with relapsed or refractory multiple myeloma (R/R MM), presented orally at the…
Verizon Communications (NYSE: VZ) is a blue chip stock worth considering -- especially if you're seeking dividend income. Its recent dividend yield was a fat 6%. Let's see how much income you might collect from the tele…
The Claude parent just shared some of its key figures with Reuters ahead of its debut. The wire service didnt reportany 2026 results, but said that Anthropic's revenue jumped more than 1,000% in 2025 to $4.6 billion. An…
(RTTNews) - HUTCHMED (HCM) announced that AstraZeneca (AZN) has submitted a New Drug Application to the U.S. FDA for ORPATHYS in combination with TAGRISSO for certain patients with advanced non-small cell lung cancer wh…
(RTTNews) - AstraZeneca (AZN) has agreed to make a $2 billion strategic equity investment in Summit Therapeutics (SMMT) while launching a clinical collaboration aimed at advancing new cancer treatment combinations invol…